Otsuka (OTSKY) Expected to Announce Earnings on Wednesday

Otsuka (OTCMKTS:OTSKYGet Free Report) will likely be announcing its resultson Wednesday, April 29th. Analysts expect the company to announce earnings of $0.4268 per share and revenue of $3.8021 billion for the quarter.

Otsuka Stock Performance

OTCMKTS:OTSKY opened at $32.76 on Wednesday. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67. The firm has a market cap of $35.19 billion and a PE ratio of 14.24. The firm has a 50 day simple moving average of $33.85 and a 200-day simple moving average of $30.33. Otsuka has a 1-year low of $21.64 and a 1-year high of $36.55.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Morgan Stanley upgraded Otsuka to an “overweight” rating in a report on Friday, January 23rd. UBS Group upgraded Otsuka to a “hold” rating in a research report on Tuesday, January 27th. The Goldman Sachs Group cut Otsuka from a “strong-buy” rating to a “strong sell” rating in a report on Friday, February 27th. Finally, Zacks Research raised shares of Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

Read Our Latest Report on OTSKY

About Otsuka

(Get Free Report)

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.

Recommended Stories

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.